APA (7th ed.) Citation

Astorgues-Xerri, L., Vázquez, R., Odore, E., Rezai, K., Kahatt, C., Mackenzie, S., . . . Riveiro, M. E. (2019). Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models. Leukemia & Lymphoma, 60(12), 3067. https://doi.org/10.1080/10428194.2019.1617860

Chicago Style (17th ed.) Citation

Astorgues-Xerri, Lucile, et al. "Insights into the Cellular Pharmacological Properties of the BET-inhibitor OTX015/MK-8628 (birabresib), Alone and in Combination, in Leukemia Models." Leukemia & Lymphoma 60, no. 12 (2019): 3067. https://doi.org/10.1080/10428194.2019.1617860.

MLA (9th ed.) Citation

Astorgues-Xerri, Lucile, et al. "Insights into the Cellular Pharmacological Properties of the BET-inhibitor OTX015/MK-8628 (birabresib), Alone and in Combination, in Leukemia Models." Leukemia & Lymphoma, vol. 60, no. 12, 2019, p. 3067, https://doi.org/10.1080/10428194.2019.1617860.